ESTROFEM Side Effects

6068196-6 | Deep Vein Thrombosis
on Jan 29, 2009 Female patient from SWITZERLAND , 78 years of age, was treated with Estrofem (View Usage). Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?). Estrofem dosage: . During the same period patient was treated with ENATEC (View Enatec Review and Enatec Label ), CALCIMAGON D 3 (View Calcimagon-d 3 Review and Calcimagon-d 3 Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), ANTRA /00661201/ (View Antra /00661201/ Review and Antra /00661201/ Label ). Patient was hospitalized.

5727237-3 | Breast Cancer Metastatic
Patient was taking Estrofem (View Usage). Patient had the following side effects: breast cancer metastatic on Apr 29, 2008 from SWITZERLAND Additional patient health information: Female patient , 86 years of age, was diagnosed with menopausal disorder, hypertension, diabetes mellitus and. Estrofem dosage: 1 Mg, Qd. During the same period patient was treated with ATACAND (16 Mg, Qd) (View Atacand Review and Atacand Label ), PLENDIL PLAIN (10 Mg, Qd) (View Plendil Plain Review and Plendil Plain Label ), DIAMICRON MR (120 Mg, Qd) (View Diamicron Mr Review and Diamicron Mr Label ), BIOTIN MEPHA (2.5 Mg, Qd) (View Biotin-mepha Review and Biotin-mepha Label ). Patient was hospitalized.

5582712-X | Breast Cancer, Breast Cancer Female
Adverse event was reported on Dec 27, 2007 by a Female patient taking Estrofem (View Usage) (Dosage: 2 Mg, Qd) was diagnosed with artificial menopause, osteopenia, hypothyroidism and. Location: TURKEY , 46 years of age, weighting 154.3 lb, After Estrofem was administered, patient had the following side effects: breast cancer (What is breast cancer?), breast cancer female. During the same period patient was treated with CALCIMAX D3 /00944201/ (2500 Mg+880 Iu, Unk) (View Calcimax D3 /00944201/ Review and Calcimax D3 /00944201/ Label ), TEFOR (.75 Tab, Qd) (View Tefor Review and Tefor Label ). Patient was hospitalized and became disabled.

5513705-6 | Breast Cancer
on Nov 01, 2007 Female patient from TURKEY , 46 years of age, weighting 154.3 lb, was diagnosed with artificial menopause, osteopenia, hypothyroidism and was treated with Estrofem (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer (What is breast cancer?). Estrofem dosage: . During the same period patient was treated with CALCIMAX D3 /00944201/ (2500 Mg+880 Iu, Unk) (View Calcimax D3 /00944201/ Review and Calcimax D3 /00944201/ Label ), TEFOR (.75 Tab, Qd) (View Tefor Review and Tefor Label ). Patient was hospitalized and became disabled.


5238788-2 | Cerebrovascular Accident
on Feb 04, 2007 Female patient from ISRAEL , 33 years of age, was diagnosed with infertility (What is infertility?) and was treated with Estrofem (View Usage). Patient had the following side effects: cerebrovascular accident. Estrofem dosage: 6 Mg/4 Days Each Mont During One Year. Patient was hospitalized.

5222517-2 | Deafness
Patient was taking Estrofem (View Usage). After Estrofem was administered, patient had the following side effects: deafness on Jan 17, 2007 from SWITZERLAND Additional patient health information: Female patient , 59 years of age, weighting 141.1 lb, was diagnosed with hot flush and. Estrofem dosage: 2 Mg, Unk.

5168439-7 | Deafness, Deafness Unilateral, Infection
Adverse event was reported on Oct 02, 2006 by a Female patient taking Estrofem (View Usage) (Dosage: 2 Mg, Unk) was diagnosed with hot flush and. Location: SWITZERLAND , 59 years of age, weighting 141.1 lb, Patient experienced the following unwanted or unexpected effects: deafness, deafness unilateral, infection (What is infection?).